Science and innovation

Explore the latest news from Etap-LAB

Contact an expert

Published on the 15 July 2024

Syncrosome as Event Partner of 3rd HF Drug Discovery & Development Summit in Boston

Syncrosome is proud to attend the next Heart Failure Drug Discovery & Development Summit as an event partner, which will take place from 31 July to 1 August 2024, in Boston (USA, MA)! We look for…

Company Science and innovation
Published on the 24 May 2024

First #fluorescencefriday – the word of our expert

🔬 We wanted to share with you one of our cell image that shows primary cortical rat neurons (DIV14) stained for PSD-95 (synapses) in green, MAP2 (dendrites) in red and DAPI (nuclei) in blue. Each litt…

Science and innovation
Published on the 11 April 2024

World Parkinson’s Day 2024 – Towards improved screening tools for Parkinson’s disease

🌍Today is World Parkinson’s Day, dedicated to increase public awareness and understanding of this disease which affects over 10 million people worldwide, making it the second leading of neurodegenerat…

Company Science and innovation
Published on the 1 March 2024

Poster AD/PD International Conference | Brain-On-Chip Project

🧠 March 5-9 – Lisbon – AD/PD International Conference | Explore the research findings of ETAP-Lab and NETRI from the BIO-DIAMOND project at the poster titled :Advancing Alzheimer's Disease Models for …

Company Science and innovation
Published on the 21 August 2023

Intracerebral administration in rat and mouse

If you need to perform intracerebral administration of your test compound, SYNCROSOME provides stereotaxic surgery in rats and mice to perform acute or chronic administration in specific brain areas a…

Science and innovation
Published on the 7 March 2023

New paper in STROKE

A new paper resulting from a collaboration between the INSERM PhIND team and STROK@LLIANCE was recently published in the journal Stroke: “Impact of Decompressive Craniectomy on Hemorrhagic Transformat…

Science and innovation
Published on the 6 February 2023

New cardiovascular model available at SYNCROSOME

Collaboration with VASA Therapeutics : characterization a heart failure model with preserved ejection fraction (HFpEF) / Dahl salt sensitive rats. Download all informations (pdf) Financial Disclosur…

Science and innovation
Published on the 15 November 2022

SfN 2022 – Poster

Our team is very proud of its first PhD Student, Florent Lebrun.He presented great results from its research work during yesterday morning poster session at the Society for Neuroscience Congress 2022 …

Science and innovation Events

Explore our scientific resources and browse posters…

Explore Our Resources